MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass.
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.
Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia.
Elevated circulating tumor necrosis factor levels in Alzheimer's disease.
Induction of circulating tumor necrosis factor cannot be demonstrated during septicemic salmonellosis in calves.
Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.
Tumor necrosis factor-alpha in pediatric HIV-1 infection.
Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules.
Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats.
Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production.
Induction of hypersensitivity to endotoxin and tumor necrosis factor by sublethal infection with Salmonella typhimurium.
Isoniazid protects mice against endotoxin lethality without influencing tumor necrosis factor synthesis and release.
Tumor necrosis factor and endotoxin can cause neutrophil activation through separate pathways.
Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis?
Rautenberg Factor: Transfusion Constraints During Cardiac Surgery.
Interleukin-6 is a better marker of lethality than tumor necrosis factor in endotoxin treated mice.
tumor necrosis factor biosynthesis at the translational level.
Tumor necrosis factor and hypermetabolism.
Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome.
Toxic shock syndrome toxin 1 enhances synthesis of endotoxin-induced tumor necrosis factor in mice.
Tumor necrosis factor-alpha.
Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment.
Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha.
Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibody.
Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery.
To study the hypothesis that endotoxin and tumor necrosis factor-alpha (TNF) are released into the circulation during the perioperative period in chil...
616KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass.
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.
Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia.
Elevated circulating tumor necrosis factor levels in Alzheimer's disease.
Induction of circulating tumor necrosis factor cannot be demonstrated during septicemic salmonellosis in calves.
Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.
Tumor necrosis factor-alpha in pediatric HIV-1 infection.
Endotoxin, interleukin-1, and tumor necrosis factor cause neutrophil-dependent microvascular leakage in postcapillary venules.
Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats.
Dehydroepiandrosterone protects mice from endotoxin toxicity and reduces tumor necrosis factor production.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms